Medical Economics September 13, 2023
American College of Cardiology, biotech companies seeking physicians to test and reduce cholesterol levels in patients.
Heart health advocates are enlisting primary care physicians in the fight against cardiovascular disease, the world’s leading killer of women and men worldwide.
The American College of Cardiology (ACC), with biotechnology companies Amgen and Esperion Therapeutics, announced the launch of “Driving Urgency in LDL Screening.” The new campaign aims to increase diagnostic low-density lipoprotein cholesterol (LDL-C) screening in patients with and without prior cardiac events and heart disease so clinicians can identify those who need treatment.
“Cardiovascular disease is preventable in many cases, and early identification of risk is essential, especially for people at high risk,” ACC Chief Medical Officer Richard Kovacs, MD, MACC,...
Today's Sponsors
Today's Sponsor